137 related articles for article (PubMed ID: 7461027)
41. Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding.
Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
Clin Pharmacol Ther; 1983 Nov; 34(5):681-8. PubMed ID: 6627828
[TBL] [Abstract][Full Text] [Related]
42. [Blood concentrations of maprotiline in depressive patients].
Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
[TBL] [Abstract][Full Text] [Related]
43. Serum protein binding of antiepileptic drugs in Sri Lankans.
Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H
Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
[TBL] [Abstract][Full Text] [Related]
44. [The concentrations of amitriptyline, maprotiline and their demethylated metabolites, nortriptyline and desmethylmaprotiline, in rat plasma and brain].
Yufu N
Seishin Shinkeigaku Zasshi; 1987; 89(1):22-42. PubMed ID: 3615663
[No Abstract] [Full Text] [Related]
45. Protein binding of doxepin and desmethyldoxepin.
Virtanen R; Iisalo E; Irjala K
Acta Pharmacol Toxicol (Copenh); 1982 Aug; 51(2):159-64. PubMed ID: 7113722
[TBL] [Abstract][Full Text] [Related]
46. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
Olsen GD; Bennett WM; Porter GA
Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
[TBL] [Abstract][Full Text] [Related]
47. Isolation and identification of hydroxylated maprotiline metabolites.
Breyer-Pfaff U; Kroeker M; Winkler T; Kriemler P
Xenobiotica; 1985 Jan; 15(1):57-66. PubMed ID: 3984384
[TBL] [Abstract][Full Text] [Related]
48. Stereoselective disposition of flurbiprofen in uraemic patients.
Knadler MP; Brater DC; Hall SD
Br J Clin Pharmacol; 1992 Apr; 33(4):377-83. PubMed ID: 1576066
[TBL] [Abstract][Full Text] [Related]
49. Fatal maprotiline intoxication.
Curtis RA; Giacona N; Burrows D; Bauman JL; Schaffer M
Drug Intell Clin Pharm; 1984 Sep; 18(9):716-20. PubMed ID: 6479020
[TBL] [Abstract][Full Text] [Related]
50. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis.
Bakaev VV; Efremov AV; Tityaev II
Nephrol Dial Transplant; 1999 Jun; 14(6):1472-4. PubMed ID: 10383010
[TBL] [Abstract][Full Text] [Related]
51. Acetaldehyde adducts with serum proteins: effect on diazepam and phenytoin binding.
Lucas D; Ménez JF; Daniel JY; Bardou LG; Floch HH
Pharmacology; 1986; 32(3):134-40. PubMed ID: 3960964
[TBL] [Abstract][Full Text] [Related]
52. Serum protein binding kinetics of phenytoin in monotherapy patients.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
J Clin Pharm Ther; 1998 Oct; 23(5):361-5. PubMed ID: 9875684
[TBL] [Abstract][Full Text] [Related]
53. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of an ultrafiltration-fluorescence polarization immunoassay for monitoring unbound phenytoin.
Argyle JC; Kinniburgh DW; Costa R; Jennison T
Ther Drug Monit; 1984; 6(1):117-20. PubMed ID: 6710555
[TBL] [Abstract][Full Text] [Related]
55. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
[TBL] [Abstract][Full Text] [Related]
56. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
[TBL] [Abstract][Full Text] [Related]
57. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
[TBL] [Abstract][Full Text] [Related]
58. Hemodialysis reduces the unbound phenytoin in plasma.
Dodson WE; Loney LC
J Pediatr; 1982 Sep; 101(3):465-8. PubMed ID: 7108673
[No Abstract] [Full Text] [Related]
59. Effect of age and sex on the plasma binding of acidic and basic drugs.
Verbeeck RK; Cardinal JA; Wallace SM
Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
[TBL] [Abstract][Full Text] [Related]
60. Protein binding of phenytoin and lidocaine in pediatric patients with type I diabetes mellitus.
Kearns GL; Kemp SF; Turley CP; Nelson DL
Dev Pharmacol Ther; 1988; 11(1):14-23. PubMed ID: 3383718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
